These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Hyper-IgE syndromes]. He YY; Liu B; Xiao XP Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 31(11):892-896. PubMed ID: 29775011 [TBL] [Abstract][Full Text] [Related]
3. An update on the hyper-IgE syndromes. Yong PF; Freeman AF; Engelhardt KR; Holland S; Puck JM; Grimbacher B Arthritis Res Ther; 2012 Nov; 14(6):228. PubMed ID: 23210525 [TBL] [Abstract][Full Text] [Related]
4. Clinical manifestations of hyper IgE syndromes. Freeman AF; Holland SM Dis Markers; 2010; 29(3-4):123-30. PubMed ID: 21178271 [TBL] [Abstract][Full Text] [Related]
10. Novel mutation in DOCK8-HIES with severe phenotype and successful transplantation. Al Shekaili L; Sheikh F; Al Gazlan S; Al Dhekri H; Al Mousa H; Al Ghonaium A; Al Saud B; Al Mohsen S; Rehan Khaliq AM; Al Sumayli S; Al Zahrani M; Dababo A; AlKawi A; Hawwari A; Arnaout R Clin Immunol; 2017 May; 178():39-44. PubMed ID: 27890707 [TBL] [Abstract][Full Text] [Related]
11. The first cohort of Iranian patients with hyper immunoglobulin E syndrome: A long-term follow-up and genetic analysis. Tavassoli M; Abolhassani H; Yazdani R; Ghadami M; Azizi G; Abdolrahim Poor Heravi S; Moeini Shad T; Kokabee M; Movahedi M; Abdshahzadeh H; Gharagozlou M; Rezaei N; Esmaeilzadeh H; Aleyasin S; Aghamohammadi A Pediatr Allergy Immunol; 2019 Jun; 30(4):469-478. PubMed ID: 30801830 [TBL] [Abstract][Full Text] [Related]
14. [Severe atopy and allergy--rare hyper-IgE syndrome caused by the DOCK8 mutation as underlying condition]. Koskenvuo M; Kainulainen L; Vanto T; Lukkarinen H; Lähteenmäki P; Ruuskanen O Duodecim; 2015; 131(6):541-4. PubMed ID: 26237897 [TBL] [Abstract][Full Text] [Related]
15. Autosomal recessive hyper-IgE syndrome caused by DOCK8 gene mutation with new clinical features: a case report. Yang J; Liu Y BMC Neurol; 2021 Jul; 21(1):288. PubMed ID: 34301197 [TBL] [Abstract][Full Text] [Related]
16. Clinical Profile of Hyper-IgE Syndrome in India. Saikia B; Rawat A; Minz RW; Suri D; Pandiarajan V; Jindal A; Sahu S; Karim A; Desai M; Taur PD; Pandrowala A; Gowri V; Madkaikar M; Dalvi A; Yadav RM; Lashkari HP; Raj R; Uppuluri R; Swaminathan VV; Bhattad S; Cyril G; Kumar H; Shukla A; Kalra M; Govindaraj G; Singh S Front Immunol; 2021; 12():626593. PubMed ID: 33717144 [No Abstract] [Full Text] [Related]
17. Diagnostic challenge in a series of eleven patients with hyper IgE syndromes. Yaakoubi R; Mekki N; Ben-Mustapha I; Ben-Khemis L; Bouaziz A; Ben Fraj I; Ammar J; Hamzaoui A; Turki H; Boussofara L; Denguezli M; Haddad S; Ouederni M; Bejaoui M; Chan KW; Lau YL; Mellouli F; Barbouche MR; Ben-Ali M Front Immunol; 2022; 13():1057679. PubMed ID: 36703986 [TBL] [Abstract][Full Text] [Related]
18. Phenotyping and long-term follow up of patients with hyper IgE syndrome. Alyasin S; Esmaeilzadeh H; Ebrahimi N; Nabavizadeh SH; Kashef S; Esmaeilzadeh E; Babaei M; Amin R Allergol Immunopathol (Madr); 2019; 47(2):152-158. PubMed ID: 30279075 [TBL] [Abstract][Full Text] [Related]
19. [Hyper-IgE syndrome. Lessons from function and defects of STAT-3 or DOCK-8]. Alcántara-Montiel JC; Vega-Torres BI Rev Alerg Mex; 2016; 63(4):385-396. PubMed ID: 27795219 [TBL] [Abstract][Full Text] [Related]
20. Clinical manifestations, etiology, and pathogenesis of the hyper-IgE syndromes. Freeman AF; Holland SM Pediatr Res; 2009 May; 65(5 Pt 2):32R-37R. PubMed ID: 19190525 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]